Wen Hair loss news very first:
— A quite busy month for Aclaris Therapeutics. Wen hair loss first the company updated its item pipeline web page and added images for each and every dermatological situation that the company’s numerous goods are supposed to treat. Then they filed for Investigational New Drug Application (IND) for their oral alopecia areata product ATI-50001 with the US FDA. Then, on November 15th the business announced positive outcomes for its topical seborrheic keratosis product (A-101) phase 3 clinical trials (webcast here) and finally, on November 16th the business announced a public providing of its widespread stock. If effective, the funds raised from this offering will partly be employed towards analysis and trials for Aclaris’ JAK inhibitor items.
— In the past month, HairClone has added the properly identified Dr. Russell Knudsen, Dr. Robert Leonard and others to their clinic partner team.
— Much more good news for alopecia areata/totalis/ universalis sufferers. This time its two individuals from Brazil who have been taking JAK inhibitor toafacitinib.
— Dr. Christophe Guillemat updated his weblog a week ago. I am nevertheless skeptical about his operate, but there is a large quantity of interest. Somebody commented in the previous that he is not a medical doctor, but I am not certain. Also see my initial post on him.
— Sharp (Japan)’s plasmacluster ion technologies promotes hair development. Sounds hard to believe. The ending of the report about lowered dandruff and itching is much more believable.
— Cellmid (Australia) raises enough funds to begin selling its Evolis line of FGF-five inhibiting hair loss merchandise in the US.
— Hairdresser Chad Gunter is extremely pleased with his PRP benefits from Dr. Laura Bennack. According to Dr. Bennack, “the most dramatic outcomes are on guys and ladies who are at the early stages of hair loss”.
— But an additional growth aspect (human hepatocyte development element) linked to advertising hair growth. Also see my recent post on the a variety of growth aspects that benefit hair growth.
— Kerastem has more US clinics participating in its clinical trials.
— Missed an important study’s findings last month: BPH drugs such as finasteride and dutasteride (each are also utilized to combat hair loss) do not raise the risk of erectile dysfunction.
— Wen hair care solution lawsuit concludes in favor of customers.
And now on to health-related products of interest:
— Gene therapy in a box courtesy of the Fred Hutchinson cancer study center.
— CRISPR gene editing tested in a individual for the first time in China.
— “Any idiot” can now generate mutant CRISPR engineered mice.
— Gene therapy to reverse particular kinds of genetically inherited blindness could be approved for use as soon as subsequent year.
— And thereafter, bionic superhuman eyes.
— Amazon’s Jeff Bezos partners with the Mayo Clinic and other people to enter the anti-aging market.
— Terminally ill 14 year old in the UK permitted to be cryogenically preserved. Also, a reality verify.
— Samantha Payne’s Open Bionics permits anyone in the globe to download and 3D print their personal bionic limbs.
— Brain implants allow paralyzed monkeys to walk. The Swiss scientist goes to China to conduct this function due to friendlier regulations. More here.
— First at-property brain implant permits paralyzed lady to communicate.
— Genetically modified pig’s heart transplanted into a monkey in South Korea breaks prior world record. The monkey survives for 51 days. Pig’s hearts are thought to be a close match to the human heart. Very cruel animal experiments, but hopefully they aid humans in future.
— Dr. Anthony Atala is nevertheless optimistic about printed organ replacements.